BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24150706)

  • 1. Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography.
    Chhablani J; Mithal K; Rao H; Narayanan R
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):549-53. PubMed ID: 24150706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescein angiography and optical coherence tomography in myopic choroidal neovascularization.
    Chhablani J; Deepa MJ; Tyagi M; Narayanan R; Kozak I
    Eye (Lond); 2015 Apr; 29(4):519-24. PubMed ID: 25613842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics.
    Chandran K; Giridhar A; Desai S; Gopalakrishnan M; Indu VP; Sivaprasad S
    Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S125-S134. PubMed ID: 38131554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2.
    Tzaridis S; Hess K; Friedlander M; Holz FG
    Br J Ophthalmol; 2021 May; 105(5):735-740. PubMed ID: 32513667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography - can we choose?
    Singh S; Agarwal M; Venkatesh R; Mayor R
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1861. PubMed ID: 25308781
    [No Abstract]   [Full Text] [Related]  

  • 6. IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Cheung CMG; Yanagi Y; Akiba M; Tan A; Mathur R; Chan CM; Yeo I; Wong TY
    Retina; 2019 Sep; 39(9):1655-1663. PubMed ID: 29927796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.
    Ong SS; Cummings TJ; Vajzovic L; Mruthyunjaya P; Toth CA
    JAMA Ophthalmol; 2019 Feb; 137(2):176-183. PubMed ID: 30476946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
    Khurana RN; Dupas B; Bressler NM
    Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization.
    Giani A; Luiselli C; Esmaili DD; Salvetti P; Cigada M; Miller JW; Staurenghi G
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5579-86. PubMed ID: 21693602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.
    Khurana RN; Hill L; Ghanekar A; Gune S
    Ophthalmol Retina; 2020 Nov; 4(11):1054-1058. PubMed ID: 32353536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes.
    Shi X; Cai Y; Luo X; Liang S; Rosenfeld PJ; Li X
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):751-758. PubMed ID: 31907643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography.
    Wilde C; Patel M; Lakshmanan A; Amankwah R; Dhar-Munshi S; Amoaku W;
    Eye (Lond); 2015 May; 29(5):602-9; quiz 610. PubMed ID: 25907206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescein angiography versus spectral domain optical coherence tomography in idiopathic juxtafoveal retinal telangiectasia.
    Chhablani J; Narayanan R
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1863. PubMed ID: 25196460
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).
    Wu L; Evans T; Arevalo JF
    Surv Ophthalmol; 2013; 58(6):536-59. PubMed ID: 24160729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 idiopathic macular telangiectasia.
    Shukla D; Gupta SR; Neelakantan N; Tiwari S; Gupta S; Patwardhan AR; Soubhya TB
    Retina; 2012 Feb; 32(2):265-74. PubMed ID: 21968508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia.
    Mandal S; Venkatesh P; Abbas Z; Vohra R; Garg S
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1825-9. PubMed ID: 17345090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT-angiography for diagnosis and response to treatment of subretinal neovascularization secondary to idiopathic macular telangiectasia type 2.
    Tapia Quijada HE; Mantolan Sarmiento C; Gómez Perera S; Serrano García M; Betancor Caro N; Haro Álvarez B
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Apr; 97(4):224-229. PubMed ID: 35523469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.